Cigna Corp (CI) Tops Q1 EPS by 30c; Boosts FY13 EPS Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
CIGNA (CI) Healthcare Profit Growth Strong - Jefferies
May 3, 2013 7:30 AM EDTJefferies lifted estimates and its price target on CIGNA (NYSE: CI) from $74 to $78 while reiterating a Buy rating.
Analyst David Windley comments, "CI's fundamentals are continuing to advance well. The company's solid 21% 1Q13 EPS beat and 2.5% EPS guidance raise start 2013 off nicely. Like... More
